Donanemab (Anti-Amyloid Beta)
Donanemab (Anti-Amyloid Beta) (A2833-GRP)
Products
Description
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research. MW : 145.36 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2833 |
| Target | Beta Amyloid |